From: High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis
Lnc RNA | Expression level | Role | micro-RNA | Downstream targets or pathways | Cell line | Function (high snhg expression) | Reference |
---|---|---|---|---|---|---|---|
SNHG1 | upregulated | oncogene | miR-101-3p | ROCK2 | A549, A549/DDP,NCI-H520/DDP | reduce cisplatin sensitivity | Wei L 2019 [54] |
SNHG1 | upregulated | oncogene | miR-101-3p | Wnt/β-catenin signaling | A549, SPC-A1, H23 and NCI-H520 | promote proliferation and cell cycle, suppress apoptosis | Cui Y 2017 [28] |
SNHG1 | upregulated | oncogene | miR-361-3p | FRAT1 | BEAS-2B, H23, H1299 | induce cell proliferation, migration,invasion, inhibit apoptosis | Li XM 2020 [42] |
SNHG1 | upregulated | oncogene | - | ZEB1 | H-266 and SK-MES-1 | promotes cell metastasis and invasion | Zhang HY 2017 [56] |
GAS5 | downregulated | tumor suppressor gene | miR-217 | LHPP | H1299, A549, A549/DDP and H1299/DDP | reduced NSCLC/DDP cell migration, invasion and EMT process, reduces cisplatin-resistance | Yang XH 2021 [55] |
SNHG3 | downregulated | tumor suppressor gene | miR-890 | - | HBE, A549, H1299, H1975 | Inhibits the Proliferation, Migration and Invasion, and Promotes the Apoptosis | Kang BJ 2021 [40] |
SNHG3 | upregulated | oncogene | miR-1343-3p | NFIX | BEAS-2B, H1299, H358, A549 and H1975 | promotes proliferation, migration and invasion and inhibits apoptosis | Zhao LJ 2021 [60] |
SNHG3 | upregulated | oncogene | - | IL‐6/JAK2/STAT3 pathway | CMT‐167, LLC, CMT‐170, and CMT‐181 | promotes proliferation and migration | Shi JD 2019 [49] |
SNHG3 | upregulated | oncogene | miR-216a | ZEB1 | A549, H322, H1299, GLC-82, and SPC-A1 | induce Proliferation, Migration and Invasion, and suppress Apoptosis | Zhao SS 2020 [21] |
SNHG4 | upregulated | oncogene | miR-let-7e | KDM3A/p21 pathway | H1299, H1650, H1975, and SPCA1 | promotes proliferation, migration and invasion and inhibits apoptosis | Wang F 2020 [50] |
SNHG5 | downregulated | tumor suppressor gene | miR-377 | miR377/CASP1 axis | PC9 and A549 | enhances gefitinib sensitivity | Wang ZX 2018 [63] |
SNHG6 | upregulated | oncogene | miR-485-3p | VPS45 | BEAS-2B, H520, H596, H1650, H1703 | induce cell growth, migration and invasion | Gao N 2020 [32] |
SNHG6 | upregulated | oncogene | miR-490-3p | RSF1, Bcl-2, bax, caspase-3 | A549, H460 and H1299 | Promotes Proliferation and Inhibits Apoptosis | Dong Z 2020 [30] |
SNHG6 | upregulated | oncogene | - | ETS1, MMP2, MMP9 | A549, H226, H292, ANP973 and H1299 | promotes proliferation and migration | Geng H 2020 [33] |
SNHG6 | upregulated | oncogene | miR-26a-5p | E2F7 | A549, H1299, H460,HCC827, NCl-H358 and NCl-H1650 | promotes cell proliferation, migration, invasion, and EMT and induces cell cycle progression | Liang R 2018 [44] |
SNHG7 | upregulated | oncogene | miR-449a | miR-449a/TGIF2 axis | BEAS-2B, A549 and H1299 | contributes to cell proliferation, migration, invasion and EMT process | Pang LL 2019 [48] |
SNHG7 | upregulated | oncogene | miR-181a-5p | AKT/mTOR Signaling Pathway | A549, NCI-H1299 | Accelerates Proliferation, Migration and Invasion | Li LP 2020 [41] |
SNHG8 | upregulated | oncogene | miR-542-3p | CCND1/CDK6 | (A549, H23, SPC-A1, and NCI-H292 | contributes to cell proliferation | Chen CH 2018 [24] |
SNHG9 | upregulated | oncogene | - | CAPRIN1 | BEAS-2B, SK-MES-1, H460, A549 and H1299 | promoted DDP resistance | Wang RX 2020 [51] |
SNHG10 | downregulated | tumor suppressor gene | miR-21 | - | KLN 205, HCC827 | increasing SNHG10 expression suppress cell proliferation | Liang M 2020 [64] |
SNHG10 | downregulated | tumor suppressor gene | miR-543 | SIRT1 | H1581 and H1703 | increasing SNHG10 expression suppress cell proliferation | Zhang Z 2020 [65] |
SNHG11 | upregulated | oncogene | miR‐4436a | Wnt/β‐catenin signaling pathway | A549, H1299, H460 | facilitated lung cancer cell prol iferation, migration, invasion, and EMT process while suppressed cell apoptosis | Liu SX 2019 [46] |
SNHG12 | upregulated | oncogene | - | HuR/PD-L1/USP8 axis | A549, SW1573, H1975, H1299 | induce immune escape | Huang YS 2022 [37] |
SNHG12 | upregulated | oncogene | miR-218 | Slug/ZEB2 signaling pathway | A549, H1299 | Accelerates Migration and EMT process | Wang Y 2019 [20] |
SNHG13 | upregulated | oncogene | miR-758-3p | - | SPC-A1 and NCI-H1299 | promotes tumor NSCLC cell migration and invasion | Wang S 2018 [52] |
SNHG13 | upregulated | oncogene | - | p21 | A549, H1299 and H358 | contributes to cell proliferation, migration, invasion and EMT process | Guo LF 2019 [34] |
SNHG13 | upregulated | oncogene | miR-1225-3p | ErbB2 | A549, SPCA1, H1299 and H1975 | Enhanced Migration and Invasion | Huang YF 2021 [38] |
SNHG13 | upregulated | oncogene | - | HMGA2 | SPCA1 and A549 | promotes invasion | Zhang NN 2021 [57] |
SNHG14 | upregulated | oncogene | miR-382-5p | SPIN1 | H1299, A549 | induce Proliferation, Migration and Invasion, and suppress Apoptosis | Chen XL 2020 [25] |
SNHG14 | upregulated | oncogene | miR-340 | - | 16HBE, A549, NCI-H1975, NCI-H1299, SK-MES-1 | induce Proliferation and suppress Apoptosis | Zhang ZH 2018 [58] |
SNHG15 | upregulated | oncogene | miR-211-3p | ZNF217 | HBEC3, H358, H1299, H23 and A549 | Promoted Proliferation and Migration | Ma XR 2019 [47] |
SNHG15 | upregulated | oncogene | miR-211-3p | - | H1799 and A549 | promotes proliferation and migration | Cui HX 2018 [27] |
SNHG15 | upregulated | oncogene | miR-486 | CDK14 | A549, H460, SK-MES-1, and Calu-3 | induce Proliferation, Migration and Invasion, and suppress Apoptosis | Jin B 2018 [39] |
SNHG16 | upregulated | oncogene | - | ALDH2, Bax, Bcl-2 | A549 and SK-LU-1 | cell proliferation | Li Y 2022 [43] |
SNHG16 | upregulated | oncogene | miR-146a | MUC5AC | A549, NCI-H292, NCI-H460, and NCI-H1703 | promotes NSCLC cell proliferation, migration and invasion | Han W 2018 [36] |
SNHG17 | upregulated | oncogene | miR-193a-5p | NETO2 | BEAS-2B, A549, H1299, H1650, H1975 and CALU-3 | facilitate migration, invasion, proliferation and EMT | Zhang ZW 2021 [59] |
SNHG18 | upregulated | oncogene | miR-211-5p | miR-211-5p/BRD4 axis | A549, H1299, H23, H460, and H1792 | promotes NSCLC cell proliferation, migration and invasion | Fan HJ 2021 [31] |
SNHG20 | upregulated | oncogene | miR-154 | ZEB2 and RUNX2 | A549, H322, H1299, GLC-82, and SPC-A1 | promotes proliferation, migration and invasion, and suppresses apoptosis | Jin LL 2019 [45] |
SNHG20 | upregulated | oncogene | - | P21 | PC9, SPC-A1, NCIH1975, H1299 and A549 | promotes cell proliferation and migration | Chen ZY 2017 [26] |
SNHG20 | upregulated | oncogene | miR-342 | DDX49 | BEAS-2B, A549 and H1299 | promoted proliferation, invasion and inhibited cell apoptosis | Wang XL 2020 [53] |